[1]
Frésard, I., Bridevaux, P. and Janssens, J. 2011. Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis. Swiss Medical Weekly. 141, 3334 (Aug. 2011), w13240. DOI:https://doi.org/10.4414/smw.2011.13240.